SHORT MINI-FUTURE - FRESENIUS MEDICAL CARE Stock

Certificat

DE000VU800W7

Delayed Deutsche Boerse AG 04:21:57 2024-06-05 EDT
14.65 EUR -1.48% Intraday chart for SHORT MINI-FUTURE - FRESENIUS MEDICAL CARE
Current month-0.27%
1 month-6.71%
Date Price Change
24-06-05 14.65 -1.48%
24-06-04 14.87 -0.34%
24-06-03 14.92 +0.07%
24-05-31 14.91 -0.60%
24-05-30 15 -4.15%

Delayed Quote Deutsche Boerse AG

Last update June 05, 2024 at 04:21 am

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU800W
ISINDE000VU800W7
Date issued 2023-06-26
Strike 54.01
Maturity Unlimited
Parity 1 : 1
Emission price 11.01
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 23.98
Lowest since issue 5.5
Spread 0.08
Spread %0.55%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.14 EUR
Average target price
39.97 EUR
Spread / Average Target
+2.13%
Consensus